アムジェンは好調な業績を報告しましたが、バーテックスや野村證券などの投資家からの反応は様々でした。 Amgen reported strong earnings, with mixed reactions from investors like Vertex and Nomura.

機関投資家はAmgen Inc.に混合されており,Vertex Planning Partners LLCは9.9%の株式を増やし,Nomura Asset Management Co. Ltd.は0.5%の株式を削減した. Institutional investors are mixed on Amgen Inc., with Vertex Planning Partners LLC increasing its stake by 9.9% and Nomura Asset Management Co. Ltd. reducing its holdings by 0.5%. アムゲンは,株当たり5.31ドルの強い利益を報告し,推定を27セント上回り,配当利回りは3.11%です. Amgen reported strong earnings of $5.31 per share, beating estimates by 27 cents, and has a dividend yield of 3.11%. エンブレルやプロリアなどの製品で知られる会社では,市場資本は160億6600億円,PE比は40.50ドルとする. The company, known for products like Enbrel and Prolia, has a market cap of $164.26 billion and a PE ratio of 40.50.